Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sarcoma, Kaposi × ixazomib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 43 Waldenstrom Macroglobulinemia 4 Recurrence 4 Lymphoma, Mantle-Cell 3 Lymphoma 2 Leukemia, Myeloid, Acute 2 Smoldering Multiple Myeloma 1 Sarcoma, Kaposi 1 Plasmacytoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Plasma Cell 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Erythroblastic, Acute 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Genetic Diseases, Inborn 1 Congenital Abnormalities 1 Amyloidosis 1

Interventions

Paclitaxel 3 Nelfinavir 3 Bevacizumab 3 pembrolizumab 2 Zidovudine 2 Valganciclovir 2 Semaxinib 2 Ritonavir 2 Propranolol 2 Interferon alpha-2 2 Indinavir 2 Filgrastim 2 Etoposide 2 Doxorubicin 2 vesnarinone 1 tocilizumab 1 tin etiopurpurin 1 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1 talimogene laherparepvec 1 nirogacestat 1 liposomal doxorubicin 1 lenvatinib 1 ixazomib 1 halofuginone 1 etoposide phosphate 1 Vincristine 1 Sunitinib 1 Saquinavir 1 Ro 24-7429 1 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305691 2026-02-27

Trial of Ixazomib for Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Recruiting

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡